ClearNote Health’s Avantect® Pancreatic Cancer Test Now Covered by Claritev’s National PPO Networks ClearNote Health, a company dedicated to advancing early detection of some of the deadliest cancers, has announced…
LGM Pharma Expands U.S. Drug Manufacturing with $6M Investment in Advanced Dosage Capabilities LGM Pharma, a leading provider of tailored API and CDMO services across the entire drug product lifecycle,…
PharmaCord and Mercalis Merge to Build Next-Gen Biopharma Platform PharmaCord and Mercalis, two leading providers of patient access and commercialization services for the biopharmaceutical industry, have announced a strategic merger…
Shift Bioscience Strengthens Leadership Team to Drive Innovation in Rejuvenation Therapeutics Shift Bioscience, a pioneering biotech company harnessing AI-powered virtual cell technology to combat age-related diseases, has announced the appointment…
New Data Reinforce the Positive Impact of Exact Sciences’ Oncotype DX® Test on Patient Care and Healthcare Efficiency Exact Sciences, a global leader in cancer screening and diagnostic solutions, has…
Hudson Therapeutics Launches Phase 2b Part 2 Trial for NuGel Hudson Therapeutics, the U.S. subsidiary of Shaperon, announced today the initiation of Phase 2b Part 2 of its clinical trial…
Merck Opens New Facility to Boost Vaccine Production Capacity Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has officially opened a new $1 billion, 225,000-square-foot…
Pharma Industry Urges Joint Action on Growing Chronic Disease Burden Ahead of a key UN milestone, the global pharmaceutical industry has launched a Call to Action to drive collective efforts…
Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing The Noramco Group, a North American provider of integrated API and drug product supply chain services, has announced…
NeoGenomics Acquires Pathline to Expand Oncology Testing in the Northeast NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology testing services, has announced the acquisition of Pathline, LLC, a CLIA/CAP/NYS-certified…
Study Confirms HER2DX® Assay’s Impact on Early-Stage HER2-Positive Breast Cancer Decisions REVEAL GENOMICS®, an innovative biotech company based in Barcelona, is excited to announce the publication of a groundbreaking study…
IMFINZI® Regimen Shows Improved Survival in Early-Stage Gastric and GEJ Cancers AstraZeneca’s innovative perioperative treatment combining IMFINZI® (durvalumab) with standard chemotherapy has shown significant improvements in survival outcomes for patients…